Our Work
Latham & Watkins Advises Ro in its US$500 Million Series D Financing
March 23, 2021
A New York-based emerging companies team advises the healthcare technology company in the transaction.
Ro, a healthcare technology company building a patient-centric healthcare system, has announced that it has raised US$500 million in its Series D funding round led by existing investors General Catalyst, FirstMark Capital, and TQ Ventures, with significant participation from existing investors SignalFire, Torch Capital, and BoxGroup as well as new investors Altimeter Capital, Baupost Group, Dragoneer Investment Group, ShawSpring Partners, Radcliff, and 776. The funding round values the New York City-based company at US$5 billion.
Latham & Watkins LLP represented Ro in the financing with an emerging companies team led by New York partner Peyton Worley, with associate Teddy Ellison.